Position in VRDN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$31,138,443
-$8,198,699 QoQ
Shares Held
1,591,945
+25.9% QoQ
Ownership
1.54%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
16 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. VRDN ranks #71 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in VRDN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31,138,443 | 1,591,945 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $39,337,142 | 1,264,047 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $16,499,247 | 764,562 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $12,579,553 | 899,825 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $16,595,119 | 1,231,092 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $17,638,201 | 920,094 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $16,818,005 | 739,253 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $13,009,231 | 999,941 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $9,510,380 | 543,140 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $8,314,231 | 381,737 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $6,124,954 | 399,280 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $7,507,100 | 315,557 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $9,028,909 | 354,910 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $7,117,717 | 243,674 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $7,583,120 | 369,728 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $1,231,397 | 66,598 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||